NCT03678987
- Conditions
- Connective Tissue Diseases, Gastrointestinal Complication, Scleroderma, Systemic, +3 more
- Locations
-
- Reumatologi SUS Lund, Region Skåne Lund, Sweden
Clinical trial condition
Scleroderma, Systemic
Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.
433 public trials
125 recruiting studies
Scleroderma, Systemic trial results
Completed
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
NCT02453256
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- TriWest Research Associates, LLC El Cajon, California, United States
- St. Joseph's Heritage Healthcare Fullerton, California, United States
- Univ of Calif., Los Angeles; Rheumatology Los Angeles, California, United States
- Arthritis Associates of Southern California Los Angeles, California, United States
NCT04274257
- Conditions
- Autoimmune Diseases, Collagen Diseases, Connective Tissue Diseases, +13 more
- Locations
-
- University of Fukui Hospital Fukui, Japan
- Chukyo Hospital Nagoya, Japan
- The University of Tokyo Hospital Tokyo, Japan
- University of Tsukuba Hospital Tsukuba, Japan
NCT03508661
- Conditions
- Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +4 more
- Locations
-
- Jewish General Hospital Montreal, Quebec, Canada
NCT02283762
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +1 more
- Locations
-
- Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
- UCLA David Geffen School of Medicine Los Angeles, California, United States
- Stanford University School of Medicine Palo Alto, California, United States
- University of Connecticut Health Center Farmington, Connecticut, United States
Completed
SPIN Self-Management Feasibility Trial
NCT03914781
- Conditions
- Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +4 more
- Locations
-
- Jewish General Hospital Montreal, Quebec, Canada
NCT00058578
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- The Methodist Hospital Houston, Texas, United States
Completed
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
NCT02597933
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +1 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California Los Angeles Los Angeles, California, United States
- University of California Davis Sacramento, California, United States
- University of California San Francisco San Francisco, California, United States
NCT03543956
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- CHU de Bordeaux - service de rhumatologie Bordeaux, France
Completed
Taking Charge of Systemic Sclerosis
NCT02494401
- Conditions
- Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States